CLINICAL_TRIALS
trial_result
· 2020-08-04
Clinical Trial Update: Ketamine for Treatment of MS Fatigue [Phase 1, Phase 2]
Summary
Clinical trial update on ketamine for fatigue in multiple sclerosis, with Phase 1 and Phase 2 completed and results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Multiple Sclerosis, Fatigue | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-04